Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis have?
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis has 420 citations in the OpenAlex counts ScholarIQ stores.
When was Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis published?
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis has 2018 year in the ScholarIQ index.
What is the open-access status of Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis?
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis has bronze oa status in the ScholarIQ index.
What is the DOI of Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis?
The DOI for Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis is on the source record.
What is the PMID of Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis?
The PMID for Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis is on the source record.
What is the OpenAlex record for Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis?
The OpenAlex for Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis is on the source record.